IPP Bureau
Janssen’s icare4u to assist people living with skin, joint and digestive disorders
By IPP Bureau - May 19, 2022
The icare4u program features a dedicated website, with comprehensive information about the diseases, videos with medical experts, and a social media community for patients and caregivers on Facebook and YouTube
CDSCO approves Jardiance for heart failure with preserved ejection fraction
By IPP Bureau - May 19, 2022
With the approval from the Central Drugs Standard Control Organisation (CDSCO), Jardiance is now the first approved therapy to improve outcomes for the full spectrum of heart failure regardless of ejection fraction
Synexa Life Sciences acquires Finnish CRO Syrinx Bioanalytics
By IPP Bureau - May 19, 2022
Expansion of leading biomarker and bioanalysis company enhances bioanalytical solutions for targeted radiopharmaceuticals
WHO validates Convidecia vaccine for Covid-19
By IPP Bureau - May 19, 2022
The vaccine was found to have 64% efficacy against symptomatic disease and 92% against severe Covid-19
Piramal Pharma Solutions new API plant in Canada goes online
By IPP Bureau - May 19, 2022
It is part of the company's CAD $30 million capital investment in the Aurora, Canada site
Dr Mansukh Mandaviya promises to introduce `Made in India’ TB infection skin test kit
By IPP Bureau - May 19, 2022
This cost-effective tool will be of immense benefit to other high burden countries as well.
Agilent companion diagnostic expands CE-IVD Mark in Europe to include cervical cancer
By IPP Bureau - May 18, 2022
Globally, cervical cancer is the fourth most common cancer among women, with approximately 30,447 new cases diagnosed in Europe in 2020
Singapore based Inspired Technology receives WHO certification
By IPP Bureau - May 18, 2022
The latest certification endorses product for cold chain monitoring across 194 WHO member countries
Innovative AI software for detection of pancreatic diseases
By IPP Bureau - May 18, 2022
As part of large-scale clinical studies prior to market introduction, the AI software has now gone into clinical test with patients, so-called first-in-human applications
Freudenberg Medical launches HelixFlex TPE tubing at Pharmapack 2022
By IPP Bureau - May 18, 2022
TPE tubing from Freudenberg also offers many different sterilization options including autoclave, gamma irradiation, x-ray, and e-beam
City of Hope and Imugene dose patient in Phase 1 trial to test cancer-killing oncolytic virus
By IPP Bureau - May 18, 2022
City of Hope is first in world to test oncolytic virus, CF33-hNIS, in people with metastatic solid tumours
Pfizer and BioNTech granted U.S. EUA for booster dose for kids 5-11 years
By IPP Bureau - May 18, 2022
Children 5 through 11 years of age are now authorized to receive a booster dose at least five months after the second dose of the two-dose primary series
ZS and Quartic to accelerate digitalization in life sciences and healthcare
By IPP Bureau - May 18, 2022
ZS and Quartic will collaborate to help drive resilience, increase adoption of Industry 4.0 and improve predictive decision-making across manufacturing
Mental wellness startup Lissun targets phygital presence in over 25 cities this year
By IPP Bureau - May 18, 2022
The centres will be located in Tier I and Tier II cities
Clinikk launches Family Physician's course to mark World Family Doctor Day on May 19
By IPP Bureau - May 18, 2022
The curriculum has been curated for General Physicians working in Clinikk
